CRSP - CRISPR Therapeutics AG Dividends

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: BEAM NTLA EDIT BMRN INCY VIR ALNY IONS VRTX JAN

| Held by: ARKK IWM XBI ARKG VXF IWN IBB VTWO SCHA SCHM

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-6.21	Insider Own	7.19%	Shs Outstand	96.39M	Perf Week	1.53%
Market Cap	5.30B	Forward P/E	-	EPS next Y	-3.70	Insider Trans	-3.11%	Shs Float	89.54M	Perf Month	2.60%
Enterprise Value	3.64B	PEG	-	EPS next Q	-1.20	Inst Own	72.77%	Short Float	29.68%	Perf Quarter	15.50%
Income	-568.53M	P/S	1291.94	EPS this Y	25.29%	Inst Trans	0.77%	Short Ratio	15.65	Perf Half Y	-2.73%
Sales	4.10M	P/B	2.92	EPS next Y	23.46%	ROA	-23.24%	Short Interest	26.57M	Perf YTD	4.73%
Book/sh	18.83	P/C	2.17	EPS next 5Y	26.48%	ROE	-31.21%	52W High	78.48 -30.02%	Perf Year	17.60%
Cash/sh	25.32	P/FCF	-	EPS past 3/5Y	8.21% -4.10%	ROIC	-22.01%	52W Low	44.12 24.48%	Perf 3Y	-2.33%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	43.09% 37.31%	Gross Margin	-5283.40%	Volatility	4.88% 5.46%	Perf 5Y	-61.47%
Dividend TTM	-	EV/Sales	888.40	EPS Y/Y TTM	-37.55%	Oper. Margin	-13408.29%	ATR (14)	2.80	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	17.96	Sales Y/Y TTM	-89.11%	Profit Margin	-13856.54%	RSI (14)	56.86	Recom	1.85
Dividend Gr. 3/5Y	- -	Current Ratio	17.96	EPS Q/Q	19.13%	SMA20	3.78%	Beta	1.69	Target Price	81.10
Payout	-	Debt/Eq	0.43	Sales Q/Q	68.55%	SMA50	4.15%	Rel Volume	2.00	Prev Close	53.98
Employees	-	LT Debt/Eq	0.42	Earnings	May 04 AMC	SMA200	-1.13%	Avg Volume	1.70M	Price	54.92
IPO	Oct 19, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	-5.05% -75.96%	Trades		Volume	3,390,880	Change	1.74%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)